New hope for stroke patients

New Australian research has found an injection of human amniotic cells can reduce brain injury and aid recovery for stroke patients.

A seven-year research project led by Professor Chris Sobey, of Melbourne’s La Trobe University, found when amnion epithelial cells (the cells lining the human amniotic sac during pregnancy and discarded after birth) were injected into a patient after suffering a stroke, its impact was less severe and recovery was significantly improved.

Brain 'switch' discovery may end yo-yo dieting

Australian scientists have discovered a ‘switch’ in the brain that regulates fat burning and may one day provide a way to control weight gain after dieting.

Associate Professor Zane Andrews of Melbourne’s Monash University said researchers found that being able to control this molecular switch, particularly after long periods of “famine”, or weight loss, may be a therapy for obesity and Type 2 diabetes.

A protein in mice, called carnitine acetyltransferase (Crat), regulated hunger-processing brain cells that controlled fat storage after dieting, he said.

Take part in our 2018 Social Survey

If you would like to help us with our research into issues concerning older people, then take part in the annual National Seniors Social Survey (NSSS), emailed to members this week.

This survey provides valuable information that we use to present our members’ views to government and the media.

This year we have asked about your experiences and understanding of aged care, particularly for services delivered at home.

We also need to know how comfortable our members are with digital devices and services delivered online.

Pharmacists welcome new pain management service

Pharmacists have welcomed a new $20 million trial by the Federal Government to support people suffering from ongoing chronic pain, the peak national body for pharmacists, the Pharmaceutical Society of Australia (PSA), said today.

Launched by Federal Health Minister Greg Hunt in Melbourne, the Pain MedsCheck program will be delivered in a partnership between the PSA and the Pharmacy Guild of Australia through community pharmacies across Australia.

Alzheimer's setback as promising drug shows no benefit in clinical trials

The quest to develop drugs to treat Alzheimer’s disease has experienced a new setback, with a promising medication failing to show benefits in the latest series of clinical trials in the UK.

The Guardian website has reported earlier trials had suggested that the drug idalopirdine, from the Danish international pharmaceutical company Lundbeck, might improve cognition in those with Alzheimer’s disease when taken alongside existing drugs – known as cholinesterase inhibitors – acting to improve symptoms rather than stopping the disease from developing.

Australians intend to work longer

Australians are retiring later, in keeping with the continuing trend to stay in the workforce for longer, new data shows.

The Australian Bureau of Statistics (ABS) said that on average in 2016-17, around 13 per cent of people aged 45 years and over were intending to continue in the workforce until they were 65, up from a decade ago when nine per cent of Australians said they would retire at 63.

“This is consistent with the continuing trend of people staying in the workforce for longer,” the ABS’s Bruce Hockman said.

Help shape the future of aged care

Aged care is a big topic at the moment and National Seniors is keen to have your input for our own research. Or you may want to take part in a government workshop and help shape the future of aged care. The details are on how to do either, or both, are below.

Tell us about your aged care experiences

National Seniors’ research team wants to hear your stories about your experiences with aged care services:

We would like you to indicate:

Featured Article